ReviewEcancermedicalscience2020
Automatic breast ultrasound: state of the art and future perspectives.
Review in Ecancermedicalscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Automated breast ultrasound (ABUS) versus handheld ultrasound (HHUS) for the preoperative assessment of tumor size in invasive breast cancer.Journal of ultrasound · 2026Article
- Portable Freehand 3D Breast Ultrasound Using a Dual-Rotary-Encoder 2DoF Tracking Framework.Sensors (Basel, Switzerland) · 2026Article
- Multimodal combined model integrating 2.5D deep learning and habitat radiomics for malignancy discrimination in ≤2 cm BI-RADS 4 breast lesions.Quantitative imaging in medicine and surgery · 2026Article
- Article
- HyFusion-X: hybrid deep and traditional feature fusion with ensemble classifiers for breast cancer detection using mammogram and ultrasound images.Scientific reports · 2025Article
- Comparative analysis of diagnostic performance of automatic breast ultrasound and spectral mammography as complementary methods to mammography examination.Polish journal of radiology · 2025Article
- Automated Breast Ultrasound for Evaluating Response to Neoadjuvant Therapy: A Comparison with Magnetic Resonance Imaging.Journal of personalized medicine · 2024Article
- Evaluating the Role of Breast Ultrasound in Early Detection of Breast Cancer in Low- and Middle-Income Countries: A Comprehensive Narrative Review.Bioengineering (Basel, Switzerland) · 2024Review
- Curated benchmark dataset for ultrasound based breast lesion analysis.Scientific data · 2024Article
- Comparative analysis of automated breast volume scanner (ABVS) combined with conventional hand-held ultrasound and mammography in female breast cancer detection.Annals of medicine and surgery (2012) · 2024Article
- Article
- Automated 3D Ultrasound as an Adjunct to Screening Mammography Programs in Dense Breast: Literature Review and Metanalysis.Journal of personalized medicine · 2023Review
- Enhanced Detection of Suspicious Breast Lesions: A Comparative Study of Full-Field Digital Mammography and Automated Breast Ultrasound in 117 Patients with Core Needle Biopsy.Medical science monitor : international medical journal of experimental and clinical research · 2023Article
- History of Mammography: Analysis of Breast Imaging Diagnostic Achievements over the Last Century.Healthcare (Basel, Switzerland) · 2023Review
- Predicting the molecular subtypes of breast cancer using nomograms based on three-dimensional ultrasonography characteristics.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The three-dimensional automated breast ultrasound system (3D ABUS) is a new device which represents a huge innovation in the breast ultrasound field, with several application scenarios of great interest. ABUS's aim is to solve some of the main defects of traditional ultrasound, such as lack of standardization, high level of skill non-reproducibility, small field of view and high commitment of physician time. ABUS has proven to be an excellent non-ionising alternative to other supplemental screening options for women with dense breast tissue; also, it has appeared to be very promising in daily clinical practice. The purpose of this paper is to present a summary of current applications of ABUS, focusing on clinical applications and future perspectives as ABUS is particularly promising for studies involving artificial intelligence, radiomics and evaluation of breast molecular subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.